Deferasirox Tablet, Film Coated
FDA Label NDC 70771-1473

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Deferasirox (NDC 70771-1473). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1471-3

Deferasirox tablets, 90 mg

30 Tablets

Rx only

Deferasirox Tablets (15e62afe 3586 4f19 B88d Cbfa30139413 01)

Deferasirox Tablets (15e62afe 3586 4f19 B88d Cbfa30139413 01)

NDC 70771-1472-3

Deferasirox tablets, 180 mg

30 Tablets

Rx only

Image (15e62afe 3586 4f19 B88d Cbfa30139413 02)

Image (15e62afe 3586 4f19 B88d Cbfa30139413 02)

NDC 70771-1473-3

Deferasirox tablets, 360 mg

30 Tablets

Rx only

Deferasirox Tablets (15e62afe 3586 4f19 B88d Cbfa30139413 03)

Deferasirox Tablets (15e62afe 3586 4f19 B88d Cbfa30139413 03)

* Please review the disclaimer below.